Nano PharmaSolutions, Inc.
- 9853 Pacific Heights Blvd, San Diego, CA 92121
- info@nanopharmasolutions.com
Social Media
Copyright © 2024 – Nano PharmaSolutions, Inc. All rights reserved. | Privacy Policy
Dr. Shrewsbury spent his first 13 years in UK clinical practice in primary care and pulmonary medicine, accepting honorary clinical positions at both the Department of Child Health at Southampton University and then the Department of Allergy and Clinical Immunology at the National Heart and Lung Institute in London. In 2000, he moved to the US and led Glaxo’s inhaled fluticasone and Upper Respiratory Inflammatory Disorders programs followed by Chiron’s Inhaled Antibiotic Core Team. Steve held the CMO position in several biotech companies including Adamas Pharmaceuticals, AVI BioPharma (now Sarepta Therapeutics), Aquinox Pharmaceuticals, and lastly at Impel Pharmaceuticals where he led drug-device combination product programs delivering drugs to the upper nasal space, in migraine, acute agitation and Parkinson’s disease. Dr. Shrewsbury qualified MB ChB in Medicine from The University of Liverpool, UK.